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Insulin attenuates intracellular calcium responses and cell contraction
caused by vasoactive agents. In the present study, we examined the
effects of insulin and insulin-like growth factor I (IGF-I) on cultured rat
mesangial cell responses to vasoactive agents. Intracellular calcium
concentration ([Ca2]) was measured with the Fura-2 method in
suspended mesangial cells. Pretreatment of mesangial cells with insulin
(from 0.05 to 5 sgIml) attenuated Ca2 transients by platelet activating
factor (PAF) in a dose dependent and a time dependent manner. Insulin
also attenuated sustained elevation of [Ca2] elicited by PAF. Basal
[Ca2]1 was not affected by insulin pretreatment. Since the effective
dose of insulin (0.5 tg/ml or higher) is much higher than the physiolog-
ical concentration, the effects of insulin may be via IGF-I receptor.
Indeed, IGF-I (50 ng/ml) similarly attenuated [Ca2i responses to PAF.
Moreover, insulin pretreatment attenuated [Ca2}1 responses evoked by
angiotensin II (Ang II) and endothelin-l. In addition, the pretreatment
with insulin or IGF-I inhibited mesangial cell contraction in response to
Ang II. The suppression of [Ca2]1 responses to vasoactive agents by
insulin was abolished when extracellular Ca2 was removed. These
data suggest that insulin, probably via IGF-I receptor, attenuates
[Ca2] responses and cell contraction of mesangial cells induced by
vasoactive agents. It is likely that the change in Ca2 influx from
outside to inside the cell underlie the effect of insulin. The modification
of mesangial cell function through IGF-I receptor may play a role in the
regulation of glomerular hemodynamics.
Available data suggest that insulin may modulate the func-
tions of vascular systems. Yagi et at reported that insulin
attenuated vasoconstrictive responses to norepinephrine and
angiotensin II (Ang II) in rabbit femoral artery and vein [1].
Similarly, Zemel et at demonstrated using aortic ring prepara-
tion that insulin shifted dose-response curves for vascular
contractile responses induced by phenylephrine and serotonin
to the higher concentration without changing maximum re-
sponses [2]. Furthermore, Standley et al reported that insulin
attenuated calcium (Ca2) transients and activation of voltage-
dependent Ca2 channel induced by vasopressin in rat vascular
smooth muscle cells [31. In addition, it was demonstrated that
vasoconstrictive responses to various agonists were enhanced
in blood vessels from both insulinopenic [4] and insulin-resis-
tant rats [2, 5]. These data suggest that insulin may attenuate
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the constrictive responses induced by various agonists in the
vascular contractile cells.
Mesangial cells, thought to be derived from mesenchyme and
share many properties with vascular smooth muscle cells, are
known to contract in response to vasoactive agents including
Ang II [6—111, platelet activating factor (PAF) [12], and endo-
thelin-l (ET-1) [13]. Increment in intracellular Ca2 concentra-
tion ([Ca2]1) is thought to mediate the signal transduction
mechanisms of these agents. In the present study, we examined
the effects of insulin on [Ca2] responses and cell contraction
caused by these agents in cultured rat mesangial cells, and
found that insulin attenuates the mesangial cell responses to
these vasoactive agents.
Methods
Cell culture
Mesangial cells were obtained by culturing isolated glomeruli
from male Wistar rats at 37°C for three to five weeks in minimal
essential medium (MEM) containing 17% fetal calf serum (FCS)
and 0.006% kanamycin under humidified air containing 5% CO2
as reported previously [6]. In the present study, we used
cultured mesangial cells of passages 3 to 8 for [Ca2]1 experi-
ments and first and second passaged mesangial cells for cell
contraction experiments if not otherwise specified.
Measurement of intracellular calcium concentration
[Ca2]1 was measured with fura-2 methods. Three to four
days before experiments, mesangial cells were subcultured and
evenly divided into several culture dishes. Prior to the [Ca2]1
measurement, these same batches of cells were exposed to
various concentrations of insulin (5 to 0.05 tgIml) or vehicle for
up to 120 minutes as specified in the text. Sixty minutes before
the end of incubation period, each batch of cells was detached
from the floor of culture dish with trypsin-EDTA solution
(containing 0.05% porcine trypsin and 0.53 mM EDTA-4Na) and
loaded with fura-2 (2.5 M) in the continued presence of insulin
or vehicle for 30 minutes at 37°C. When fura-2 loading was
completed, each batch of cells was resuspended in the appro-
priate experimental solution and [Ca2]1 measurement was
done immediately after the Ca2 signal was stabilized. The ratio
of 500 nm fluorescence signal obtained by exciting the cell with
340 and 380 nm wavelength (R) was monitored at 37°C using a
dual excitation monochrometer (CAF-1 10; Jasco, Tokyo, Ja-
pan) in a cuvette under constant stirring. At the end of every
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experiment, the maximum ratio of 500 nm fluorescence (Rmax)
of each aliquot was obtained by permeabilizing cells with 0.1%
Triton X and the minimum ratio of 500 nm fluorescence (Rmjn)
was obtained by adding EGTA (final concentration: 20 mM).
[Ca2] was calculated from these parameters as reported
previously [14]. When the effect of extracellular Ca2 was
examined, the incubation with insulin or vehicle was done in the
presence of Ca2. The experimental solution was changed
immediately to Ca2 free solution before the [Ca2]1 measure-
ment and [Ca2] measurement was completed within five
minutes. For calibration, 20 l of 100 mrt CaC12 solution was
added, and Rmax and Rmjn were obtained.
Cell contraction
Mesangial cell contraction was evaluated using a semiquan-
titative analytical method as we reported previously [7]. In
brief, cells were partially detached from the floor of culture dish
by incubation at 37°C for 10 to 15 minutes in phosphate buffered
saline (PBS) containing 0.54 mri EDTA. The cells thus treated
were incubated again in MEM containing 17% FCS at 37°C for
30 minutes under humidified air containing 5% CO2. Then the
medium was changed to an experimental solution containing
0.8% BSA in the presence of insulin or vehicle. After 30
minutes of incubation at 37°C, photographs of randomly se-
lected areas were taken before and at 50 to 70 seconds after the
addition of 100 nrvi Ang II. Comparing the cell shape before and
after Ang II addition, the percentage of the cells showing
unequivocal shape changes was calculated.
Solutions and reagents
The composition of the standard experimental solution was
(in mM): Na 150, K 6, Ca2 1.2, Mg2 1.0, Hepes 20, C1
140, and glucose 5.5; pH 7.4. Ca2 free solution contained 1 ifiM
EGTA in the absence of Ca2. NaOH (10—s N or less) was used
for the vehicle of insulin, and acetic acid (l0— N) was used for
that of insulin-like growth factor I (IGF-I). PAF, Ang II, ET-1
and trypsin-EDTA solution were purchased from Sigma Chem-
ical Co. (St. Louis, Missouri, USA). Insulin was obtained from
BIOSYS S.A. (Compiegne, France) and IGF-I was purchased
from GIBCO BRL (Gaithersburg, Maryland, USA).
Statistics
The data are presented as mean SD. Paired t analysis was
used for statistical analysis unless otherwise specified. Re-
peated measures analysis of variance (ANOVA) was also used
to test overall differences between groups. P value less than
0.05 was taken as significant. There was no discrepant signifi-
cance obtained even if the results were analyzed with paired t
analysis or ANOVA.
Results
Effects of insulin on basal [Ca2 and [Ca2 ]j responses to
PAF
Figure 1A represents the effect of insulin on the [Ca2]1
response to 100 nM PAF in cultured rat mesangial cells. Both
the peak of Ca2 + transient and the sustained elevation of [Ca2
following Ca2 transient were apparently attenuated by the
pretreatment with 5 g/ml insulin for 120 minutes. Including
other experiments, Figure lB shows the means SD of the
basal [Ca2]1 and the peak value of [Ca2]1 induced by PAF (N
= 11). Insulin pretreatment did not affect the basal [Ca2]1 (82.3
19.7 n vs. 87.3 21.5 nrs, insulin(—) vs. (+); N = 11), while
the peak value of [Ca2]1 induced by PAF was significantly
attenuated by insulin (267.0 13.1 n vs. 220.5 19.0 nM,
insulin(—) vs. (+); N = 11, P <0.01). The increment in [Ca2]1
induced by PAF was significantly less in insulin treated mesan-
gial cells than the untreated control cells (184.7 18.7 n vs.
133.2 16.3 ns, insulin(—) vs. (+); N = 11, P <0.01; Fig. 1C).
Moreover, insulin pretreatment significantly attenuated sus-
tained elevation of [Ca2]1 elicited by 100 nrvt PAF (the incre-
ment in [Ca2]1: 47.2 17.4 vs. 29.1 17.5, insulin(—) vs. (+);
N = 11, P <0.01; Fig. 1D). Similar to the results obtained in
multiple (3rd to 8th) passaged cells as mentioned above, insulin
also attenuated [Ca2i responses to PAF in early (the first and
the second) passaged mesangial cells (data not shown).
The effect of insulin was time- and dose-dependent as shown
in Figures 2 and 3, and Tables 1, and 2. Thus, the time-course
experiments show that the effects of insulin on Ca2 transients
induced by 100 nM PAF were apparent after 30 minutes
preincubation with 5 pg/ml insulin, while insulin pretreatment
for five minutes did not affect Ca2 transients induced by PAF
(Fig. 2, Table 1). Dose-dependency of insulin effects is shown in
Figure 3 and Table 2. In this series of experiments, a 120-minute
preincubation period was chosen. The effects of insulin on Ca2
transients induced by 100 nM PAF were obvious at the concen-
trations higher than 0.5 tg/ml.
In all these experiments, the basal [Ca2]1 value was not
affected by insulin pretreatment. Furthermore, it was ascer-
tained that the addition of 5 pg/ml insulin or vehicle per se had
no effects on [Ca2}1.
Effects of insulin on [Cd]1 responses to Ang II and ET-1
We also examined the effects of insulin pretreatment on
[Ca2]1 responses to Ang II and ET-1 (Figs. 4 and 5). Pretreat-
ment of mesangial cells with 5 g!ml insulin for 120 minutes
attenuated significantly the peak value of [Ca2]1 induced by
100 nM Ang II (Fig. 4), and that induced by 100 nM ET-l (Fig.
5). Insulin significantly attenuated the sustained elevation of
[Ca2]1 elicited by ET-1 (data not shown). As the sustained
elevation of [Ca2]1 elicited by Ang II was not detectable, we
did not examine the effects of insulin on sustained phase of
[Ca2]1 responses to Ang II.
Effects of insulin on [Ca2]1 responses to PAF in the absence
of extracellular Ca2
To elucidate the role of extracellular Ca2 in the attenuation
of [Ca2}1 responses to vasoactive agents by insulin, we exam-
ined the effects of insulin on [Ca2]1 responses induced by 100
nM PAF in the absence of extracellular Ca2. In the absence of
extracellular Ca2, both the basal [Ca2]1 and the Ca2 tran-
sient induced by PAF (Fig. 6A, middle panel) were suppressed
compared with those in the presence of extracellular Ca2 (Fig.
6A, left panel), and the sustained elevation of [Ca2]1 by PAF
disappeared completely. More importantly, removal of extra-
cellular Ca2 abolished the attenuating effect of insulin in
contrast with the observation in the presence of extracellular
Ca2 (Fig. 6A, middle and right panels). Figure 6B represents
the means SD of the basal [Ca2]1 and the peak value of
[Ca2], induced by PAF in the absence of extracellular Ca2 (N
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Fig. 1. [Ca2]1 responses of mesangial cells
to PAF after the pretreatment in the presence
of 5 g/ml insulin or vehicle for 120 ?ninutes.
(A) The effect of insulin pretreatment on the
[Ca2]1 response induced by 100 nM PAF.
Preincubation with insulin did not affect the
basal [Ca211, while Ca2 transient induced by
PAF was markedly attenuated by insulin
pretreatment. (B) The basal [Ca2] and the
peak value of [Ca2]1 induced by 100 nM PAF
from eleven independent experiments. There
was no significant change induced in the basal
[Ca2]1, whereas the peak value of [Ca2]
was significantly suppressed by insulin
pretreatment.
= 6). Neither the basal [Ca2]1 nor the peak value of [Ca2J1
induced by PAF was altered by insulin pretreatment (5 pg/m1,
120 mm) in the absence of xtracel1u1ar Ca2t Similar results
were obtained in the responses caused by 100 flM Ang II (data
not shown).
Effects of IGF-I on [Ca2] responses to PAF
Since the effective dose of insulin (0.5 gIml) was 100- to
1000-fold higher than its physiological concentration, it is
reasonable to assume that the effects of insulin are via IGF-I
receptor. Therefore, we examined the effects of IGF-I on
[Ca2]1 responses to PAF in mesangial cells. IGF-I at the
concentration of 50 nglml, a concentration almost equivalent to
that found in vivo, was used. Similar to insulin pretreatment,
IGF-I pretreatment for 120 minutes did not affect the basal
[Ca2 i, while the peak value of [Ca2]1 induced by 100 flM PAF
was significantly attenuated by IGF-I (Fig. 7A). Also, IGF-I
significantly attenuated sustained elevation of [Ca2] elicited
by PAF (Fig. 7B). Similar to insulin, it was ascertained that the
addition of 50 nglml IGF-I or vehicle per se had no effects on
[Ca2
Effects of insulin and IGF-I on cell contraction induced by
Ang 11
The effects of insulin and IGF-I on mesangial cell contraction
were evaluated using a semiquantitative analytical method as
we previously reported [7]. Pretreatment with 5 pg/ml insulin
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Fig. 1. Cont'd (C) The increment in [Ca24]1 induced by PAF. The increment in [Ca211 was significantly suppressed by insulin pretreatment. (D)
The increment in [Ca24]1 of the sustained elevation of [Ca211 induced by PAF (2 mm after the addition of PAF). Insulin pretreatment attenuated
significantly the increment in [Ca24]1 in the sustained phase. The values in B, C, and D are means SD. < 0.01 vs. the value in the absence
of insulin.
Table 1. Time-course of insulin effect on [Ca2i1 responses to PAF
Fig. 2. Time-course of insulin effect on
[CaJ, responses to PAF. The basal [Ca24]3
and the peak value of [Ca24], induced by 100
nM PAF from five independent experiments.
The cells were pretreated in the presence of 5
g/ml insulin for 0, 5, 30, and 120 minutes,
respectively. The effects of insulin on [Ca24]1
were significant after 30 minutes of
incubation. The values are means SD.
0.05 vs. the value in the presence of insulin
for 0 minutes (control).
[Ca2]1
Duration of insulin pretreatment
0 mm
(control) 5 mm 30 mm 120 mm
Base nM
Peak nM
Increment nM
Inhibition of the increment
in [Ca21, vs. control %
69.2 4.9
265.2 13.3
196.0 10.2
88.1 15.7
287.6 42.8
199.5 16.4
—1.8
82.2 13.1
247.6 7.8a
165.4 175b
15.6
90.4 23.3
226.8 27.9a
136.4
30.4
The data represent mean SD of five experiments.
a p < 0.05 vs. the value in the presence of insulin for 0 mm (control)
b P < 0.01 vs. control
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Table 2. Dose-dependency of insulin effect on [Ca2J1 responses to PAF
Insulin 0.05 pg/mI 0.5 pg/mI 5 pg/mI
Insulin (-s-)
Fig. 3. Dose-dependency of the insulin effect on [Ca2], responses to
PAF. The basal [Ca2]1 and the peak value of [Ca2]L induced by 100 flM
PAF from six independent experiments are shown. The cells were
pretreated with vehicle, 0.05, 0.5, or 5 g/ml insulin, respectively, for
120 minutes. The basal value was not affected. The effects of insulin
were significant at the concentration higher than 0.5 tg/m1. The values
are means 5D. < 0.05 vs. the value in the absence of insulin. **
<0.01 vs. the value in the absence of insulin.
Insulin (—) Insulin (÷)
Fig. 4. [Ca24], responses to Ang ii after the pretreatment with 5 pg/ml
insulin or vehicle for 120 minutes. The basal [Ca2]1 and the peak value
of [Ca2]1 induced by 100 nM Ang II are from six independent
experiments. [Ca24J responses induced by Ang II were similarly
suppressed by insulin pretreatment. The values are means SD. *P <
0.05 vs. the value in the absence of insulin.
Insulin (—) Insulin (+)
Fig. 5. [Ca], responses to ET-1 after the pretreatment with 5 sg/ml
insulin or vehicle for 120 minutes. The basal [Ca241, and the peak value
of [Ca2], induced by 100 nas ET-l are from six independent experi-
ments. [Ca2i responses induced by ET-1 were similarly suppressed by
insulin pretreatment. The values are means SD. < 0.05 vs. the
value in the absence of insulin.
for 30 minutes, which was ascertained to affect significantly
[Ca2]1 signal as described above, suppressed cell contraction
in response to 100 nM Ang 11(52 8% vs. 35 10%, insulin(—)
vs. (+); N = 5, P < 0.01; Fig. 8A). Also, cell contraction in
response to Ang II was significantly attenuated by the pretreat-
ment with SOng/mi IGF-I (62 16% vs. 44 11%, IGF-I(—) vs.
(+); N = 5, P <0.05; Fig. 8B).
Discussion
Insulin sg/ml
0
[Ca2], (control) 0.05 0.5 5
Base nM 104.2 10.1 108.2 18.5 100.0 22.6 104.6 6.0
Peak nM 203.6 53.0 214.0 43.3 187.0 34.Oa 169.6 52.8a
Increment nM 99,4 44.4 105.8 44.8 87.0 43,9" 65.0 44.4"
Inhibition of the increment —6.4 12.5 34.6
in [Ca2]1 vs. control %
The data represents mean SD of six experiments.
a p < 0.05 vs. the value in the absence of insulin (control)
l, P < 0.01 vs. control
C'
0 0
0
The present study clearly demonstrated that insulin attenu-
ated [Ca2]1 responses and cell contraction of mesangial cells to
vasoactive agents. As shown in a series of experiments using
PAF, the suppressive effect of insulin was time- and dose-
dependent. Since the effective doses of insulin were 100 to 1000
times higher than physiological insulin concentrations, the
attenuating effects of insulin may be mediated via IGF-I recep-
tor. Indeed, pretreatment of mesangial cells with 50 ng/ml (7
nM) IGF-I, which is thought to be almost equivalent to the
physiological range, attenuated [Ca2] responses induced by
PAF and cell contraction caused by Ang II to the similar extent
to the effect of 5 jsg/ml insulin. Therefore it is likely that the
effects of insulin seen in the present study may be through
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Fig. 6. Effects of insulin on (Ca2 responses
to PAF in the absence of extracellular Ca.
(A) The effect of insulin pretreatment on the
[Ca2]1 response induced by 100 nat PAF in
the absence of extracellular Ca2. In the
absence of extracellular Ca2, both the basal
[Ca2]1 and the Ca2 transient induced by
PAF (middle) were suppressed compared with
those in the presence of extracellular Ca2
(left), and the sustained elevation of [Ca2]1
by PAF disappeared completely. More
importantly, removal of extracellular Ca2
abolished the effect of insulin in contrast with
the observation in the presence of
extracellular Ca2 (middle and right). (B) The
basal [Ca2'11 and the peak value of [Ca2i
induced by 100 nM PAF (means SD) are
from six independent experiments. Neither
the basal [Ca2] nor the peak value of [Ca24]
was altered by 5 g/m1 insulin pretreatment
for 120 minutes when Ca2 measurement was
done in the absence of extracellular Ca2t
IGF-I receptors in mesangial cells. Several investigators dem-
onstrated that insulin stimulates the incorporation of [3H]thy-
midine into DNA through IGF-I receptor in mesangial cells [15,
16], data compatible with our results.
In contrast to our present reports, Kreisberg reported that
insulin was required for mesangial cell contraction in response
to Ang II [17]. There are several differences in experimental
protocols between the study of Kreisberg and ours. Firstly, in
their experiments, cells were exposed to insulin for more than
one week, much longer period than the incubation time adopted
in the present study, that is, the attenuating effect of insulin on
the responses to Ang II was obvious within 30 minutes. This
may indicate that our results represent more rapid modulation
of mesangial cell functions by insulin than their observations.
Besides, the cells used in their experiments were multiple
passaged (the 3rd to 8th passages) cells while we used very
early passaged cells, that is, the first and second passaged cells.
Since contractile capacity of mesangial cells is diminished after
multiple passages, the difference in passage may explain that
our very early passaged cells could contract in the absence of
insulin pretreatment while multiple passaged cells failed to
contract in the absence of insulin as reported by Kreisberg.
However, the exact reason of the discrepant results concerning
the effects of insulin on mesangial cell contraction remains
unknown.
The effects of insulin on [Ca2]1 responses to vasoactive
agents were not detectable in the absence of extracellular Ca2.
Furthermore, sustained elevation of [Ca2]1 elicited by PAF
and ET- 1, which was completely abolished in the absence of
extracellular Ca2 (Fig. 6), was also suppressed by insulin
pretreatment (Fig. 1D). These data suggest that insulin affects
[Ca2]1 in mesangial cells by modulating Ca2 influx induced by
vasoactive agents across plasma membranes. In accordance
with this notion, Standley et al using patch clamp technique,
showed that insulin reduced agonist-induced Ca2 influx in rat
vascular smooth muscle cells [3]. Therefore, the present study
indicates that insulin, via IGF-I receptor, affects Ca2 signal in
mesangial cells by inhibiting the Ca2 entry pathway.
The present observation that IGF-I receptor activation atten-
uates mesangial cell responses to vasoactive agents might be
related to the physiological modulation of glomerular function.
It is generally believed that mesangial cells modulate intraglom-
erular hemodynamics by affecting glomerular filtration coeffi-
cient (Kr) [18—20]. There are reports from different laboratories
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Fig. 7. Effects of IGF-I on [Ca2'71 responses to PAF. (A) The basal
[Ca2]1 and the peak value of [Ca211 induced by 100 nM PAF are from
six independent experiments. The basal [Ca2]1 was not affected,
whereas the peak value of [Ca2i was significantly suppressed by 50
ng/ml IGF-I pretreatment for 120 minutes. (B) The increment in [Ca211
of the sustained elevation of [Ca2]1 induced by PAF (2 mm after the
addition of PAF). IGF-I pretreatment attenuated significantly the incre-
ment in [Ca21, on the sustained phase. The values in A and B are
means SD. **P < 0.01 vs. the value in the absence of IGF-I.
ci)0
V
ci)
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8
0
IGF-I (—) IGF-l (+)
Fig. 8. Mesangial cell contraction in response to Ang Ii after the
pretreatment with 5 pg/ml insulin (A) or 50 ng/ml IGF-I. (B). In
mesangial cells treated with 5 .tg/ml insulin or 50 ng/ml IGF-I for 30
mm, cell contraction in response to Ang II was suppressed. < 0.05
vs. the value in the absence of insulin. < 0.01 vs. the value in the
absence of insulin.
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that Ang II, which cause mesangial cell contraction, decreased
Kf in vivo [19, 21—23]. In an animal model whose mesangial cells
were lysed with anti-Thy-i antibody, Blantz et al showed that in
the glomeruli lacking in mesangial cells, the regulation of
glomerular functions by Ang II was disturbed [24]. Therefore, it
is possible that IGF-I modulates glomerular hemodynamics
through affecting mesangial cell responses to vasoactive agents
including Ang II, ET-i, and PAF. In this context, Hirschberg et
al reported intriguing observations that infusion of IGF-I actu-
ally increases glomerular filtration rate (GFR) through increas-
ing K [251. Furthermore, it has been shown that mesangial cells
produce and secrete IGF-I [261. These observations, together
with the present findings, strongly suggest that IGF-I acts as an
autocrine/paracrine manner through affecting mesangial cell
contractility and indicate the important role of IGF-I in the
regulation of glomerular function.
In addition to IGF-I, there remains a possibility that insulin
modulates glomerular hemodynamics through altered mesangial
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cell function. There were reports that insulin binding or insulin
receptors were present in glomeruli [27, 28]. Tucker et a! [29]
reported that renal vasodilation was caused by acute hyperin-
sulinemia in non-diabetic rats leading to increased nephron
blood flow and glomerular ultrafiltration without altered Kf,
results somewhat different from the study by Hirschberg et al
with IGF-I infusion [25]. Most reports indicate either no change
or a reduction in Kf in early diabetes. These observations may
suggest that the modulation of glomerular hemodynamics could
occur through insulin receptors, although an increase in K in
vivo may require unphysiologically high concentrations of in-
sulin, meriting the role of IGF-I rather than insulin in the
modulation of K in glomeruli.
To further strengthen the important role of IGF-1, it is
reported that the increase in IGF-I receptor expression is
present in diabetic mesangial cells [301. This observation,
together with the present data, may suggest the importance of
pathophysiological role of IGF-I in mesangial cells in diabetes
mellitus. However, the exact significance of IGF-I receptor
overexpression is unknown.
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